Clinical Trial Information Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Evaluate the Efficacy, Safety and Tolerability of Efzofitimod in Patients With Systemic Sclerosis Related Interstitial Lung Disease Protocol Number: 16338 Status: Open Age Group: Adult Treatment Type: Treatment Secondary Protocol No.: ATYR1923-C-005 Phase: II NCT ID: NCT05892614 Scope Information Scope: National Disease Site(s): Other
